Muntañola Ana, Bosch Francesc, Arguis Pedro, Arellano-Rodrigo Eduardo, Ayuso Carmen, Giné Eva, Crespo Marta, Abrisqueta Pau, Moreno Carol, Cobo Francesc, López-Guillermo Armando, Montserrat Emili
Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.
J Clin Oncol. 2007 Apr 20;25(12):1576-80. doi: 10.1200/JCO.2006.08.4194. Epub 2007 Mar 12.
Whether computed tomography (CT) should be routinely included in the diagnostic work-up in patients with chronic lymphocytic leukemia (CLL) has not yet been determined. The aim of this study was to analyze the prognostic significance of abdominal CT in patients with CLL in Rai clinical stage 0.
Abdominal CT was performed at diagnosis in 140 patients consecutively diagnosed with CLL in Rai stage 0 disease.
An abnormal abdominal CT was found in 38 patients (27%). Abnormal CT correlated with increased bone marrow infiltration (P = .024), high lymphocyte count (P = .001), increased ZAP-70 expression (P = .003), and short lymphocyte doubling time (LDT; P = .007). Patients with abnormal CT progressed more frequently and had a shorter time to progression than those with normal CT (median, 3.5 years v not reached, respectively; P < .001) and required earlier treatment intervention. In a multivariate analysis, only high ZAP-70 expression (relative risk = 3.60) and an abnormal abdominal CT (RR = 2.71) correlated with disease progression.
In this series, an abnormal abdominal CT was a strong predictor of progression in patients with early-stage CLL. The inclusion of CT scans in the initial work-up of patients with early clinical stage on clinical grounds can, therefore, provide relevant clinical information.
计算机断层扫描(CT)是否应常规纳入慢性淋巴细胞白血病(CLL)患者的诊断检查尚未确定。本研究的目的是分析腹部CT对Rai临床分期为0期的CLL患者的预后意义。
对140例连续诊断为Rai 0期疾病的CLL患者在诊断时进行腹部CT检查。
38例患者(27%)腹部CT异常。CT异常与骨髓浸润增加(P = 0.024)、淋巴细胞计数高(P = 0.001)、ZAP-70表达增加(P = 0.003)和淋巴细胞倍增时间(LDT)短(P = 0.007)相关。CT异常的患者比CT正常的患者进展更频繁,进展时间更短(中位数分别为3.5年和未达到;P < 0.001),并且需要更早的治疗干预。在多变量分析中,只有高ZAP-70表达(相对风险 = 3.60)和腹部CT异常(RR = 2.71)与疾病进展相关。
在本系列研究中,腹部CT异常是早期CLL患者疾病进展的有力预测指标。因此,基于临床理由在早期临床分期患者的初始检查中纳入CT扫描可提供相关临床信息。